New-onset atypical fulminant type 1 diabetes after COVID-19 vaccination: A case report.

Takaaki KobayashiFumiyoshi YakouMasuo SaburiAi HiroseHiroaki AkaokaYusuke HirotaDaisuke YunaiyamaNobuteru AsahiAtsushi OhnoTakaya Matsushita

Published in: Clinical case reports (2022)

Adverse reactions, including the onset of diabetes, after coronavirus disease 2019 (COVID-19) vaccination have been reported. Herein, we report a case of a man who developed anti-glutamic acid decarboxylase (GAD) antibody-positive fulminant type 1 diabetes 15 weeks after COVID-19 vaccination, atypical of the previously reported anti-GAD antibody-negative cases.

Keyphrases

coronavirus disease
type diabetes
sars cov
glycemic control
respiratory syndrome coronavirus
cardiovascular disease
insulin resistance
emergency department
preterm birth
adverse drug